Engels M, Gehrmann K, Falhammar H, Webb E A, Nordenström A, Sweep F C, Span P N, van Herwaarden A E, Rohayem J, Richter-Unruh A, Bouvattier C, Köhler B, Kortmann B B, Arlt W, Roeleveld N, Reisch N, Stikkelbroeck N M M L, Claahsen-van der Grinten H L
Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands.
Eur J Endocrinol. 2018 Mar;178(3):285-294. doi: 10.1530/EJE-17-0862. Epub 2018 Jan 16.
Current knowledge on gonadal function in congenital adrenal hyperplasia (CAH) is mostly limited to single-center/country studies enrolling small patient numbers. Overall data indicate that gonadal function can be compromised in men with CAH.
To determine gonadal function in men with CAH within the European 'dsd-LIFE' cohort.
Cross-sectional clinical outcome study, including retrospective data from medical records.
Fourteen academic hospitals included 121 men with CAH aged 16-68 years. Main outcome measures were serum hormone concentrations, semen parameters and imaging data of the testes.
At the time of assessment, 14/69 patients had a serum testosterone concentration below the reference range; 7 of those were hypogonadotropic, 6 normogonadotropic and 1 hypergonadotropic. In contrast, among the patients with normal serum testosterone (55/69), 4 were hypogonadotropic, 44 normogonadotropic and 7 hypergonadotropic. The association of decreased testosterone with reduced gonadotropin concentrations (odds ratio (OR) = 12.8 (2.9-57.3)) was weaker than the association between serum androstenedione/testosterone ratio ≥1 and reduced gonadotropin concentrations (OR = 39.3 (2.1-732.4)). Evaluation of sperm quality revealed decreased sperm concentrations (15/39), motility (13/37) and abnormal morphology (4/28). Testicular adrenal rest tumor (TART)s were present in 39/80 patients, with a higher prevalence in patients with the most severe genotype (14/18) and in patients with increased current 17-hydroxyprogesterone 20/35) or androstenedione (12/18) serum concentrations. Forty-three children were fathered by 26/113 patients.
Men with CAH have a high risk of developing hypothalamic-pituitary-gonadal disturbances and spermatogenic abnormalities. Regular assessment of endocrine gonadal function and imaging for TART development are recommended, in addition to measures for fertility protection.
目前关于先天性肾上腺皮质增生症(CAH)患者性腺功能的知识大多局限于纳入患者数量较少的单中心/国家研究。总体数据表明,CAH男性患者的性腺功能可能受到损害。
确定欧洲“dsd-LIFE”队列中CAH男性患者的性腺功能。
横断面临床结局研究,包括来自病历的回顾性数据。
14家学术医院纳入了121例年龄在16 - 68岁的CAH男性患者。主要结局指标为血清激素浓度、精液参数和睾丸影像学数据。
在评估时,14/69例患者的血清睾酮浓度低于参考范围;其中7例为低促性腺激素性,6例为正常促性腺激素性,1例为高促性腺激素性。相比之下,血清睾酮正常的患者(55/69)中,4例为低促性腺激素性,44例为正常促性腺激素性,7例为高促性腺激素性。睾酮降低与促性腺激素浓度降低的关联(比值比(OR)= 12.8(2.9 - 57.3))弱于血清雄烯二酮/睾酮比值≥1与促性腺激素浓度降低的关联(OR = 39.3(2.1 - 732.4))。精子质量评估显示精子浓度降低(15/39)、活力降低(13/37)和形态异常(4/28)。80/39例患者存在睾丸肾上腺残余肿瘤(TART),在基因型最严重的患者中患病率更高(14/18),在当前17 - 羟孕酮升高(20/35)或雄烯二酮(12/18)血清浓度升高的患者中患病率也更高。26/113例患者育有43名子女。
CAH男性患者发生下丘脑 - 垂体 - 性腺功能紊乱和生精异常的风险较高。除了采取生育保护措施外,建议定期评估性腺内分泌功能并进行TART发育的影像学检查。